Sponsor

Second Affiliated Hospital of Xi'an Jiaotong University

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Second Affiliated Hospital of Xi'an Jiaotong University appears in 17 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials17
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

17 shown
A Study on the Efficacy of Immunotherapy, the Occurrence and Severity of Adverse Reactions in Patients with Non-small Cell Lung Cancer in High-altitude AreasNCT06757114 · lead sponsor · 2025-01-01
UNKNOWN
Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor FailureNCT06336954 · lead sponsor · 2024-03-30
NOT_YET_RECRUITING
Characteristics of Intestinal Microbiome in the Progression of Early COPDNCT04876833 · lead sponsor · 2021-05-01
UNKNOWN
Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLCNCT04182698 · lead sponsor · 2019-11-22
UNKNOWN
The Effect of Conbercept Injection Through Different Routes for Neovascular GlaucomaNCT03154892 · lead sponsor · 2017-04-01
COMPLETED
Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General AnesthesiaNCT02289391 · lead sponsor · 2014-12-01
UNKNOWN
Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled TrialNCT02178319 · lead sponsor · 2014-06-01
UNKNOWN
Dexmedetomidine Influence on the Level of Perioperative Blood Glucose and Insulin of Elderly Diabetes PatientsNCT02154074 · lead sponsor · 2014-05-01
UNKNOWN
Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive PatientsNCT06558877 · collaborator · 2025-06-20
RECRUITING
Chronic Airway Disease and Multimorbidity CohortNCT06798077 · collaborator · 2025-02-01
RECRUITING
Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted BiopsyNCT04271527 · collaborator · 2024-02-20
UNKNOWN
ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLCNCT05198154 · collaborator · 2022-01-24
ACTIVE_NOT_RECRUITING
Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver DiseaseNCT03796975 · collaborator · 2018-06-28
COMPLETED
NSE/Alb as a Prognostic Biomarker for Lung CancerNCT03724604 · collaborator · 2017-01-01
UNKNOWN
Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 DiabetesNCT02449603 · collaborator · 2015-11-01
COMPLETED
Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary HypertensionNCT01637675 · collaborator · 2013-05-01
UNKNOWN
Study of Qiliqiangxin Capsule to Treat Dilated CardiomyopathyNCT01293903 · collaborator · 2012-01-01
COMPLETED

Drugs studied in this sponsor's trials

4 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Second Affiliated Hospital of Xi'an Jiaotong University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
dexmedetomidine1
exenatide1
isoflurane1
placebo1

Sponsor roles

collaborator9
lead sponsor8
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.